Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
Titel:
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
Auteur:
Obach, Victor Velasco, Fernando Alvarez Escudero, Rocio Martín Bujanda, María Aranceta, Sonsoles Fabregat, Neus Marco, Teresa Ruisanchez, Aintzine Roncero, Natalia Mínguez-Olaondo, Ane Ruibal, Marta Guisado-Alonso, Daniel Moreira, Antia Cuadrado-Godia, Elisa Echeverria, Amaya Kortazar Zubizarreta, Izaro López-Bravo, Alba Riesco, Nuria González-Fernández, Lucia Pola, Nuria Manera, Paula Guerrero-Peral, Ángel Luis Oterino Duran, Agustín González-Osorio, Yésica Armand, Rosario Fernández-Fernández, Santiago García-Azorín, David García-Moncó, Juan Carlos